COMRAD - comparative radiation hybrid mapping
 
introduction
background
participants
maps and markers
projects
Roslin Institute

 

Markers

BTA 5

Framework markers
Marker ID
Primer 1
Primer 2
Retention Frequency
Gene Name
F3
AGLA254
GCTGCTTGGCACAGGCAAA
GGATTAATTTCTGGACTCTG
0.17
 
F2
AGLA293
GAAACTCAACCCAAGACAACTCAAG
ATGACTTTATTCTCCACCTAGCAGA
0.277
 
 
BL23
TCAATCCCTGGGTCAGGAAG
CTTATTTCAAAATTCGGTTGGG
0.237
 
 
BL4
AAATTTTTCATCCTTCTTTCTGAC
TCACCCTGACTGTGAATGC
0.151
 
 
BM1819
AGCACTGTGGGAATTATGGG
TGGAATGAGCCAGCTCAAG
0.202
 
F4
BM2830
AATGGGCGTATAAACACAGATG
TGAGTCCTGTCACCATCAGC
0.228
 
 
BM315
TGGTTTAGCAGAGAGCACATG
GCTCCTAGCCCTGCACAC
0.194
 
F2
BM321
AAGGGTCAGACAAAACTTAGCA
ATCCTTGCCCTAATTCTCATTC
0.326
 
 
BM6026
GCAACTAAGACCCAACCAAC
CATCGTGAATTCCAGGGTTC
0.29
 
F4
BM733
ATGCTCCTTGTGCTCTCACC
GCCATAGGAGAAAAACTTGGG
0.204
 
 
BM8126
TCTTCCTCCGCAGACTGG
GAACCTGTGGATGAGCGG
0.258
 
 
BM8230
GTAATTCTGGACACGACACACA
TTAAGGATATGCAGAGGGTGTT
0.17
 
F2
BMC1009
GCACCAGCAGAGAGGACATT
ACCGGCTATTGTCCATCTTG
0.269
 
F1
BMS1095
AGGGATTGGTTTATGCTCTCTC
GTTGCAGAGTCGGACATGAC
0.272
 
 
BMS1216
GAGTAGAACACAACTGAGGACACA
CAATGCTGTGGGTACTGAGG
0.223
 
F3
BMS1248
GTAATGTAGCCTTTTGTGCCG
TCACCAACATGAGATAGTGTGC
0.204
 
F2
BMS1315
AAGCCATTGATTGTAGATTGGG
GAGTTTCCTTTTTCCCCCAC
0.312
 
 
BMS1617
GCCTGCATGTGTCTGTGG
TCTGTGTCGGAATACCCTCC
0.151
 
F4
BMS1658
ATTGATGCTTTATGATCCTCATG
CCCACTAAGAGAGGAGGAGG
0.187
 
 
BMS1898
GACATCACTTTGGGGCATG
TCTCCCCACCTCTTCCATC
0.277
 
F3
BMS490
TCACCAGGAAAGTCTCTATTTGG
ATATGCATCAACTCACACTGCC
0.165
 
F5
BMS597
AGAAGAAGAGCAAGAGCAAAGG
AAGAAGACCTCTCTGACCCTCC
0.258
 
F1
BMS610
TTTCACTGTCATCTCCCTAGCA
ATGTATTCATGCACACCACACA
0.286
 
F1
BMS695
CAATTAAAAAACCCTGACAGCA
TGTCCAAGAAGATCAGGTCTCA
0.312
 
 
BMS722
TTGTGCAATCAAGTGGTAACTG
CTCACTAAGATGCCTGGTGATC
0.287
 
 
BP1
AAAATCCCTTCATAACAGTGCC
CATCGTGAATTCCAGGGTTC
0.217
 
 
BR2936
GAGCCTTGTGGGCTACAGTC
GAAGATTGCAAATGGAAAGACC
0.213
 
F4
CD9*
GAGTCAAGCTTTGTGCCCTG
GTACAATATCTTTTGTCTAGAG
0.277
CD9 antigen
 
CSSM22
TCTCTCTAATGGAGTTGGTTTTTG
ATATCCCACTGAGGATAAGAATTC
0.202
 
 
CSSM34
CCATAACTCTGGGACTTTTCCTCA
ATGTTCAGCCATCTCTCCTTGTCC
0.308
 
 
ETH10
GTTCAGGACTGGCCCTGCTAACA
CCTCCAGCCCACTTTCTCTTCTC
0.194
 
F5
ETH152
TACTCGTAGGGCAGGCTGCCTG
GAGACCTCAGGGTTGGTGATCAG
0.287
 
 
ETH2
CCCACAGGTGCTGGCATGGCC
CCATGGGATTTGCCCTGCTAGCT
0.198
 
F5
IDVGA9
GTCAGGTCTAAACCCAGAGCC
TCAAAAGGGCAGAGTTCCAC
0.309
 
F3
ILSTS066
TGGAGGTTTGGGATTGGAGG
GAGTATGGAGTGACTGAGGG
0.215
 
 
KR71B
GCTCCTCGGTTCTCACCTCT
CTGGATGCCTGAAGGACAAG
0.258
 
 
MAF23
GTGGAGGAATCTTGACTTGTGATAG
GGCTATAGTCCATGGAGTCGCAG
0.301
 
 
MAF48
TCACTAAACCAGGGGCGG
GAGGCAGGCAAAATCAGAAC
0.33
 
 
MYF5
ACAGCGTCTACTGTCCTGATG
CGTGGCATATACTAAGGACAC
0.245
 
 
OVO182
TGTAGTTTCCAAGCTGAACGGCA
TATCTCGGCAATCGGCTCTAACG
0.298
 
F2
OVO190
ATCTTTACTTTTGAAACAGG
GCAGCATGTCATACTCAACT
0.223
 
F2
OVO251
TTGATTCTCTGCTAGGCCTG
GTCATTCTTGGCACTGTTTC
0.255
 
 
OVO268
CATCACTCCAGAGTGGATTG
CCTTCGACTCTGATCGCCTT
0.255
rhodopsin
 
RHOD*
ACGTGCCTTTCTCCAACAAGAC
TCTTGTGCTGGACTGTGACGTA
0.234
 
 
RM029
ATATGTCTCTGCATATCTGTTTAT
CTAATCCCATAGTGAGCAGACC
0.223
 
 
RM103
TCTGTGCACTTTACATTTAACAGA
GTGGTCTATTGAACTTTTGTTCAGA
0.255
 

back to main choice

© Roslin Institute 2002

Dr John Williams
0131 527 4200